产品中心 抗体 功能性抗体

所有图片(1/1)

Invivo anti-Human CD16 Recombinant mAb

Low affinity immunoglobulin gamma Fc region receptor III-A,IgG Fc receptor III-A,CD16-II,CD16a antigen,Fc-gamma RIII-alpha (Fc-gamma RIII,Fc-gamma RIIIa,FcRIII,FcRIIIa,FcgammaRIIIA),FcR-10,IgG Fc receptor III-2,CD16a,FCG3,FCGR3,IGFR3,FCGR3A

价格 询价 请咨询客服
货号 S0B7074
规格
数量
收藏 分享

产品介绍 评论(0)

产品规格
  • 宿主来源

    Mouse
  • 抗原名称

    CD16
  • 分子别名

    Low affinity immunoglobulin gamma Fc region receptor III-A; IgG Fc receptor III-A; CD16-II; CD16a antigen; Fc-gamma RIII-alpha (Fc-gamma RIII; Fc-gamma RIIIa; FcRIII; FcRIIIa; FcgammaRIIIA); FcR-10; IgG Fc receptor III-2; CD16a; FCG3; FCGR3; IGFR3; FCGR3A
  • 细胞定位

    Secreted, Cell membrane
  • Accession

    P08637
  • 克隆号

    3G8
  • 抗体类型

    Mouse mAb
  • 抗体同种型

    IgG1,k
  • 同型对照

    Invivo mouse IgG1 isotype control
  • 反应种属 ?

    Hu
  • 阳性样本

    Human peripheral blood lymphocytes
  • 纯化方式

    Protein G
  • 浓度

    5 mg/ml
  • 标记

    Unconjugated
  • 性状

    Liquid
  • 缓冲体系

    PBS pH7.4

  • 储存条件

    2 to 8 °C for 2 weeks under sterile conditions;
    -20 °C for 3 months under sterile conditions;
    -80 °C for 24 months under sterile conditions.
    Please avoid repeated freeze-thaw cycles.

  • 应用

    in vitro blocking

    in vitro cell specific stimulation/activation

    FCM

  • 稀释度

    应用 稀释度 推荐种属
    FCM 1:500 Hu
背景介绍
  • CD16, also known as FcγRIII, is a type of glycoprotein belonging to the immunoglobulin superfamily. It is divided into two subtypes: CD16a (FcγRIIIa) and CD16b (FcγRIIIb). CD16a is a transmembrane protein mainly expressed on natural killer (NK) cells, monocytes, and some T cell subsets, while CD16b is a GPI-anchored protein primarily found on neutrophils. CD16a can mediate antibody-dependent cell cytotoxicity (ADCC) by binding to the Fc region of IgG antibodies, which is crucial for the immune system to eliminate virus-infected cells and cancer cells. Additionally, CD16a is one of the core markers for defining NK cells and can promote their proliferation and secretion of cytotoxic cytokines. In cancer immunotherapy, CD16a is an important target protein, and some monoclonal antibody drugs are designed to enhance its binding ability to boost immune responses.

  • 流式分析

    • Flow cytometric analysis of human peripheral blood lymphocytes labelling Human CD16 antibody at 1/500 dilution (1 μg) / (right panel) was compared with a Mouse IgG1, κ Isotype Control / (left panel). Goat Anti-Mouse IgG Alexa Fluor® 488 was used as the secondary antibody. Then cells were stained with CD56 - Phycoerythrin antibody separately. Total viable cells, as determined by Fixable Viability Dye 452 (S0D0021), were used for analysis. Flow cytometry and data analysis were performed using Agilent NovoCyte Quanteon and FlowJo™ software.

评论(0)